Pharmaceutical Care,MTM,& Payment: The Past,Present,& Future

Abstract

Central to any discussion of payment reform is the need for a rational scientific medication use system to ensure that drug-related morbidity and mortality are minimized. The care provision process is based on a comprehensive assessment of all of a patient's drug-related needs and it behooves pharmacists to conduct a comprehensive assessment as do all other health professions. This comprehensive assessment is the foundation of medication therapy management (MTM) services provided within the practice of pharmaceutical care. Care can be delivered in the community by clinically oriented pharmacists, although building a practice is hard work much different from the business of dispensing medications. The number of pharmacists needed to provide comprehensive MTM services for every American is projected to range from 30,000 to 100,000 based on data/experiences from Minnesota, Ontario, and elsewhere. These individuals may benefit from some type of provider recognition so that society can differentiate between pharmacists who provide comprehensive MTM services and those in drug distribution roles. Approaching the legislature and policymakers with cost savings data, partnering with the business community, and focusing on dual eligible patients and those with unmet mental hearth needs are important strategies to make this practice transformation a reality.

Keywords

CPT codes drug-related morbidity and mortality medication therapy management payment reform pharmaceutical care

Get full access to this article

View all access options for this article.

References

Cipolle

, Strand

, Morley

. Pharmaceutical care practice: The clinician's guide. New York: McGraw-Hill, 2004.

Sonnedecker

. Kremers and Urdang's history of pharmacy. 4th ed. Madison, WI: American Institute of the History of Pharmacy, 1977.

American Society of Consultant Pharmacists. History of consultant pharmacists. https://www.ascp.com/about-us/history (accessed 2011 Jul 18).

Smith

, Giuliano

, Starkowski

. In Connecticut: improving patient medication management in primary care. Health Affairs 2011; 30:646–54.

Johnson

, Bootman

. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med 1995; 155:1949–56.

Ernst

, Grizzle

. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc 2001; 41:192–9.

Engleberg Center for Health Reform at Brookings and the Dartmouth Institute for Health Policy and Clinical Practice. Brookings-Dartmouth Accountable Care Organization Toolkit. Washington, DC: The Brookings Institution 2011: 119. https://xteam.brookings.edu/bdacoln/Documents/ACO%20Toolkit%20January%202011.pdf (accessed 2011 Jul 18).

Martin A, Lassman D, Whittle L, Catlin A, National Health Expenditure Accounts Team. Recession contributes to slowest annual rate of increase in health spending in five decades. Health Aff (Millwood) 2010; 30:11–22.

Aspen

, Wolcott

, Bootman

eds. Preventing medication errors. Institute of Medicine. Washington: National Academy Press, 2007.

10.

Isetts

, Buffington

. CPT code-change proposal: national data on pharmacists' medication therapy management services. J Am Pharm Assoc 2007; 47:491–5.

11.

American Medical Association. CPT changes 2006: an insider's view. Chicago: American Medical Association, 2005: 309–12.

12.

Smith

, Bates

, Bodenheimer

, Cleary

. Why pharmacists belong in the medical home. Health Aff (Millwood) 2010; 29:906–13.

13.

Patient-Centered Primary Care Collaborative. The patient-centered medical home: Integrating comprehensive medication management to optimize patient outcomes. 2010. http://www.pcpcc.net/content/medication-management (accessed 2011 Jul 18).

14.

Carr

. A quotation with a life of its own. Quotation often attributed to Donald Berwick, W. Edward Deming, and Paul Batalden as a guiding principle for quality improvement. Patient Safety & Quality Healthcare E-Newsletter, July/August 2008. http://www.psqh.com/julaug08/editor.html (accessed 2011 Jul 18).

15.

Brown

, Isetts

. Patient assessment and consultation. In: Berardi

ed. Handbook of nonprescription drugs. 16th ed. Washington, DC: American Pharmacists Association, 2009: 15–32.

16.

Medicare Payment Advisory Commission, Hackbarth GM, chair. Report to the Congress: Medicare coverage of nonphysician practitioners. Washington, DC, June 2002: 21–26. http://www.medpac.gov/documents/jun02_NonPhysCoverage.pdf (accessed 2011 Jul 19).

17.

Centers for Medicare and Medicaid Services. Medicare Part D Medication Therapy Management (MTM) Programs. 2011 fact sheet, updated June 30, 2011. http://www.cms.gov/PrescriptionDrugCovContra/Downloads/MTMFactSheet2011063011Final.pdf (accessed 2011 Jul 18).

18.

American Medical Association. About CPT. http://www.ama-assn.org/ama/pub/physician-resources/solutions-managing-your-practice/codingbilling-insurance/cpt/about-cpt.page? (accessed 2011 Jul 19).

19.

Porter

, Teisberg

. Redefining health care: creating value-based competition on results. Boston: Harvard Business School Press, 2006.

20.

Pharmacist Services Technical Advisory Coalition. Medication Therapy Management Service Codesat. http://www.pstac.org/services/mtms-codes.html (accessed 2011 Jul 19).

21.

Cranor

, Bunting

, Christensen

. The Asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003; 43:173–90.

22.

Bluml

, McKenney

, Cziraky

. Pharmaceutical care services and results in Project ImPACT: hyperlipidemia. J Am Pharm Assoc 2000; 40:157–65.

23.

Goode

, Swiger

, Bluml

. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: osteoporosis. J Am Pharm Assoc 2004; 44:152–60.

24.

Bluml

. Definition of medication therapy management: development of profession-wide consensus. J Am Pharm Assoc 2005; 45:566–72.

25.

American Pharmacists Association, National Association of Chain Drug Stores Foundation, et al. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc 2008; 48:341–53.

26.

Medicaid to pay Mississippi pharmacists for disease management. Am J Health Syst Pharm 1998; 55:1238–9.

27.

HMOs adopt Wisconsin Medicaid pilot project for commercial enrollees. Payment Strat Pharmaceut Care 1998; 3:1, 2,5–8.

28.

Chrischilles

, Carter

, Lund

. Evaluation of the Iowa Medicaid pharmaceutical case management program. J Am Pharm Assoc 2004; 44:337–49.

29.

Michaels

, Jenkins

, Pruss

, Heidrick

, Ferreri

. Retrospective analysis of community pharmacists' recommendations in the North Carolina Medicaid medication therapy management program. J Am Pharm Assoc 2010; 50:347–53.

30.

National Conference of State Legislatures. Medication therapy management: pharmaceutical safety and savings, updated June 2011. http://www.ncsl.org/default.aspx?tabid=19064 (accessed 2011 Jul 1).

31.

State of Minnesota— Medicaid Medication Therapy Management Care Program documents and information. http://www.dhs.state.mn.us/ (accessed 2011 Jul 1).

32.

Isetts

. Evaluating effectiveness of the Minnesota Medicaid Medication Therapy Management Care Program—Report to the Legislature. State Contract Number B00749, Posted December 14, 2007. http://www.dhs.state.mn.us/main/groups/business_partners/documents/pub/dhs16_140283.pdf (accessed 2011 Jul 1).

33.

Affordable Care Act, 2010: Medication management services in treatment of chronic diseases: grants or contracts to implement medication management services in treatment of chronic diseases. Public Law 111–148, companion Reconciliation Act PL. 111–152, Title m, Subtitle A, Sec. 3503, Public Health Services Act, 42 U.S.C. 201.2010 Amendments to the P.H.S. Act, Sec. 935, (pps. 1055–1061). http://www.healthcare.gov/center/authorities/title_iii_improving_the_quality_and_efficiency.pdf (accessed 2011 Jul 1).

34.

Goldman

. The reliability of peer assessments: a meta-analysis. Eval Health Prof 1994; 17:3–21

35.

Isetts

, Brown

, Schondelmeyer

, Lenarz

. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Intern Med 2003; 163:1813–20.

36.

Pharmacy Quality Alliance, Medication Therapy Management Work Group. http://www.pqaalliance.org/MTMCare.htm (accessed 2011 Jul 18).

37.

Fairview Health System—medication therapy management program. http://www.fairview.org/Pharmacy/MedicationTherapyManagement/index.htm (accessed 2011 Jul 18).

38.

Rosser

, Colwill

, Kasperski

, Wilson

. Progress of Ontario's family health team model: a patient-centered medical home. Ann Fam Med 2011; 9:165–71.

39.

Rosser

, Colwill

, Kasperski

, Wilson

. Patient-centered medical homes in Ontario. N Engl J Med 2010; 362:e7.

40.

Losinski

. Educating for action: understanding the development of pharmaceutical care practitioners. A Ph.D. dissertation presented to faculty of the Graduate School of the University of Minnesota, May 23, 2011.

41.

Chisholm-Burns

, Lee

, Spivey

. US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care 2010; 48:923–33.